日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The molecular mechanism of ambrosin-induced cytotoxicity of human breast cancer and bladder cancer cells.

安布罗辛诱导人乳腺癌和膀胱癌细胞细胞毒性的分子机制

El-Sawy Layla, Rubin John R, Broses Luke, Patsalis Christopher, Henderson Marian L, Wilson Steven J, Glase Shelly A, Munson Katherine A, Hiles Guadalupe Lorenzatti, Cates Angelica, Emamdjomeh Amir, Chou Andrew, Farber Joseph, Kampf Jeff W, Magnuson Brian, Liebert Monica, Paulsen Michelle T, Van Golen Kenneth, Ljungman Mats, Bankhead Armand 3rd, Palmbos Phillip L, Day Kathleen C, Day Mark L

A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy

TROPHY-U-01 研究(队列 2)简明摘要:在无法接受顺铂类化疗的转移性尿路上皮癌患者中,免疫治疗后使用 sacituzumab govitecan 的疗效

Grivas, Petros; Tagawa, Scott T; Jain, Rohit K; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P; Davis, Nancy; Sternberg, Cora N; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing

通过基于指南的检测方法检测局限性和转移性前列腺癌患者的种系变异

Abusamra, Sophia M; Solorzano, Marissa A; Quarles, Jake; Luke, Mallory; Patel, Milan; Vince, Randy Jr; Jiang, Ralph; Volin, Joshua; Jacobs, Michelle F; Kaffenberger, Samuel D; Salami, Simpa S; Palmbos, Phillip; Caram, Megan E V; Hollenbeck, Brent K; Palapattu, Ganesh S; Merajver, Sofia D; Stoffel, Elena M; Hafron, Jason; Morgan, Todd M; Reichert, Zachery R

TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy

TROPHY-U-01 队列 2:一项针对既往接受过免疫检查点抑制剂治疗后进展且不适合顺铂治疗的转移性尿路上皮癌患者的 Sacituzumab Govitecan II 期研究

Petrylak, Daniel P; Tagawa, Scott T; Jain, Rohit K; Bupathi, Manojkumar; Balar, Arjun; Kalebasty, Arash Rezazadeh; George, Saby; Palmbos, Phillip; Nordquist, Luke; Davis, Nancy; Ramamurthy, Chethan; Sternberg, Cora N; Loriot, Yohann; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Vance, Morganna; Zhou, Huafeng; Grivas, Petros

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

在 IMPACT II 期试验中评估免疫检查点阻断疗法对伴有 CDK12 有害改变的转移性去势抵抗性前列腺癌的疗效

Nguyen, Charles B; Reimers, Melissa A; Perera, Chamila; Abida, Wassim; Chou, Jonathan; Feng, Felix Y; Antonarakis, Emmanuel S; McKay, Rana R; Pachynski, Russell K; Zhang, Jingsong; Reichert, Zachery R; Palmbos, Phillip L; Caram, Megan E V; Vaishampayan, Ulka N; Heath, Elisabeth I; Hopkins, Alexander C; Cieslik, Marcin P; Wu, Yi-Mi; Robinson, Dan R; Baladandayuthapani, Veerabhadran; Chinnaiyan, Arul M; Alva, Ajjai S

A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer

TROPHY-U-01 研究的简明语言摘要:sacituzumab govitecan 用于治疗局部晚期或转移性尿路上皮癌

Loriot, Yohann; Kalebasty, Arash Rezazadeh; Fléchon, Aude; Jain, Rohit K; Gupta, Sumati; Bupathi, Manojkumar; Beuzeboc, Philippe; Palmbos, Phillip; Balar, Arjun V; Kyriakopoulos, Christos E; Pouessel, Damien; Sternberg, Cora N; Tonelli, Julia; Sierecki, Mitch; Zhou, Huafeng; Grivas, Petros; Barthélémy, Philippe; Bangs, Rick; Tagawa, Scott T

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics

利用功能化微流体技术表征转移性膀胱癌患者的循环肿瘤细胞

Zeqi Niu, Molly Kozminsky, Kathleen C Day, Luke J Broses, Marian L Henderson, Christopher Patsalis, Rebecca Tagett, Zhaoping Qin, Sarah Blumberg, Zachery R Reichert, Sofia D Merajver, Aaron M Udager, Phillip L Palmbos, Sunitha Nagrath, Mark L Day

Intronic Cis-Element DR8 in hTERT Is Bound by Splicing Factor SF3B4 and Regulates hTERT Splicing in Non-Small Cell Lung Cancer

hTERT 中的内含子顺式元件 DR8 与剪接因子 SF3B4 结合并调节非小细胞肺癌中的 hTERT 剪接

Aaron L Slusher #, Jeongjin J Kim #, Mark Ribick, Jesse Pollens-Voigt, Armand Bankhead, Phillip L Palmbos, Andrew T Ludlow

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors

TROPHY-U-01:一项针对铂类化疗和免疫检查点抑制剂治疗后进展的转移性尿路上皮癌患者的 Sacituzumab Govitecan II 期开放标签研究

Tagawa, Scott T; Balar, Arjun V; Petrylak, Daniel P; Kalebasty, Arash Rezazadeh; Loriot, Yohann; Fléchon, Aude; Jain, Rohit K; Agarwal, Neeraj; Bupathi, Manojkumar; Barthelemy, Philippe; Beuzeboc, Philippe; Palmbos, Phillip; Kyriakopoulos, Christos E; Pouessel, Damien; Sternberg, Cora N; Hong, Quan; Goswami, Trishna; Itri, Loretta M; Grivas, Petros

A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

一项随机II期研究,比较雄激素剥夺疗法联合或不联合帕博西尼治疗RB阳性转移性激素敏感性前列腺癌的疗效

Palmbos, Phillip L; Daignault-Newton, Stephanie; Tomlins, Scott A; Agarwal, Neeraj; Twardowski, Przemyslaw; Morgans, Alicia K; Kelly, Wm Kevin; Arora, Vivek K; Antonarakis, Emmanuel S; Siddiqui, Javed; Jacobson, Jon A; Davenport, Matthew S; Robinson, Dan R; Chinnaiyan, Arul M; Knudsen, Karen E; Hussain, Maha